News & Articles
Results per page
2255 Articles Found | Selected Filters:
Protein identified as new therapeutic anti-viral target for COVID-19
The research also found the presence of detectable viral RNA in blood in COVID-19 patients is a strong predictor of mortality
NHS opens eight UK clinical trial sites to assess cancer patient response to immunotherapy in collaboration with OncoHost
OncoHost’s AI-Based proteomic profiling platform, PROphet, to serve key role in host response evaluation of late-stage disease patients
Large-scale lung cancer clinical study demonstrates accuracy and sensitivity of Fluxion’s ERASE-Seq liquid biopsy
356-patient concordance study confirms performance using head-to-head testing vs. droplet digital PCR
Watch highlights from the Virtual Cancer and Immunology Research Summit 2021
Top talks presenting the latest technologies, research and applications are now available on demand
COVID-19 Vaccine AstraZeneca effective against Delta (‘Indian’) variant
Real-world data demonstrated 92% vaccine effectiveness against hospitalisations due to the Delta variant
SARS-CoV-2 variants: Are Ct values an unused piece of the profiling puzzle?
Infectious disease scientist Dr. Padmapriya Banada explores the potential of cycle threshold values and reveals her melt-based assay alternative
Your next tissue diagnostics educational journey awaits! Introducing the immunohistochemistry free summer webinar series, from Merck
This multi-session event will take you on a weekly path of discovery, featuring the latest in IHC antibodies, histology troubleshooting techniques, case studies in pathology, and more
Ultrasensitive antigen test detects SARS-CoV-2 and influenza viruses
Novel chip-based diagnostic technology can detect individual viral antigens in nasal swab samples to identify the viruses that cause COVID-19 and flu with a single test
Roche obtains CE mark for the SARS-CoV-2 Antigen Self-Test Nasal allowing for rapid self-testing of COVID-19 at home
The test will be widely available to individuals through pharmacies and other locations in accordance with local guidelines and testing strategies
PerkinElmer to donate COVID-19 antigen tests to combat the second wave in India
Much-needed diagnostics supplies will help accelerate testing capabilities of hospitals and clinics across India
The value of routine diagnostic parameters in supporting COVID-19 disease management
Guest editorial: Learn how clinicians can utilize diagnostic information to make decisions when examining suspected SARS-CoV-2 patients
Beckman Coulter launches Access AMH Advanced, an innovative test for clinicians to better personalize IVF treatments
The new Access AMH Advanced aims to provide validated cut-offs for the assessment of ovarian reserve and ovarian response as an aid for women undergoing in vitro fertilization (IVF)
Antigen testing: Addressing the critical need for rapid and sensitive COVID-19 testing
From its expedited development to its far-reaching adoption, COVID-19 antigen testing is helping students and workforces safely return to daily life
Virtual Clinical Science Summit 2021: Full meeting agenda
Watch world-leading clinical scientists and healthcare professionals online, June 22-23, to discover the latest tools and techniques advancing COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more
Explore hot topics at these 10 free webinars coming up this week
Catch up on topics from A-TEEM spectroscopy and DNA sequencing to advances in in vitro diagnostics, advancing nano-material research with wet-chemical synthesis and biopharmaceutical R&D
Welsh lighthouse laboratory extends contract with PerkinElmer for its COVID-19 solutions
Company’s RT-PCR kits and workflow solutions will continue to safeguard capacity for NHS Test and Trace laboratory
Siemens Healthineers lab-based antigen test available on high-throughput analyzers to support COVID-19 testing
The fast time-to-result includes a pretreatment process to inactivate the virus as a safeguard for laboratory staff handling the samples
Mission Bio’s Tapestri Platform used to distinguish acute myeloid leukemia clones from CHIP clones
New findings pave way to potentially improved assessment of measurable residual disease in AML patients
























